Dr. David G. Cupp, MD

Dr. Cupp practices at Vitreo-Retinal Medical Group, Inc in Roseville, California.

Dr. Cupp's NPI, 1497901565, was assigned on August 8, 2008. Dr. Cupp graduated from Penn State College of Medicine in 2008. Dr. Cupp's California license number on file is A120754.

Dr. Cupp's primary practice is Vitreo-Retinal Medical Group, Inc, at 1680 E Roseville Pkwy, Roseville, CA 95661 in Placer County. The practice phone is (916) 774-0100.

Dr. Cupp's primary practice is Vitreo-Retinal Medical Group, Inc in Roseville, California. Dr. Cupp is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Cupp to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cupp practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Cupp's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Cupp is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Cupp's licenses on file in 2 states: California and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Cupp treats.

CMS data shows 59,756 Medicare services from Dr. Cupp across 28 procedure codes in 2024, for 1,823 Medicare patients. Medicare paid $4,093,340 for them.

CMS counts 1,823 Medicare patients who saw Dr. Cupp in 2024. The largest group is 65 to 74, with 689 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cupp's median patient age at 70, with 53% women.

In 2024, Dr. Cupp wrote 790 Medicare Part D claims for 299 patients. 63% of them were for generic drugs. CMS names the drug for 741 of them, across 10 drugs with 11 or more claims each, at $24,053 in total drug cost. In 2023, CMS named 657 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Cupp for performance year 2024, reported as part of a group. Dr. Cupp accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Cupp, published from 2006 to 2012. The most frequent topics are Biological Transport, Fatty Acids, Nonesterified and Kinetics.

CMS Open Payments shows 91 general payments to Dr. Cupp from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $1,084.

Dr. Cupp graduated from Penn State College of Medicine in 2008.

Dr. Cupp is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.